Professional
Added to YB: 2024-10-25
Pitch date: 2024-10-23
PCHM [bullish]
PharmChem, Inc.
+13.64%
current return
Author Info
Cedar Creek Partners provides deep-dive research on undervalued companies. Follow on Twitter/X.
Company Info
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana.
Market Cap
$15.2M
Pitch Price
$3.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-9.37
EV/Sales
N/A
Sector
Health Care Equipment and Supplies
Category
value
Cedar Creek Partners Portfolio Holding: PharmChem, Inc.
PCHM: Sweat patch drug test maker. Q2 EPS $0.123 ($0.079 ex-options). 7.1% H1 patch sales growth (ex-top customer). Fund owns 33%, chairman role. $0.25 special dividend paid. Bid price up to $3.36/share in Q3.
Read full article (1 min)